Erlotinib
【Molecular composition】:
【CAS NO】:183321-74-6
【source】:Erlotinib
【authentication】:US FDA / Mexico COFEPRIS
【specifications】:Form A/Form B
【DMF】:Available
【use to】:
Erlotinib is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.